BioCorRx (BICX) Assets Average (2011 - 2026)

BioCorRx has disclosed Assets Average across 16 years of filings, most recently posting $2.2 million for Q1 2026.

• Assets Average for Q1 2026 came in at $2.2 million, down 37.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 37.78% YoY), and the FY2025 annual result was $1.3 million, up 226.93% from the prior year.
• Assets Average came in at $2.2 million for Q1 2026 at BioCorRx, down from $4.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $7.1 million in Q3 2025 to a low of $353165.5 in Q1 2024.
• The 5-year median for Assets Average is $792921.5 (2022), against an average of $1.9 million.
• Across the five-year window, Assets Average tumbled 57.61% in 2022 and soared 1593.76% in 2025, its largest moves.
• BioCorRx's Assets Average stood at $792921.5 in 2022, then plunged by 41.78% to $461666.5 in 2023, then climbed by 11.5% to $514755.5 in 2024, then surged by 836.92% to $4.8 million in 2025, then tumbled by 53.64% to $2.2 million in 2026.
• The last three Assets Average figures came in at $2.2 million (Q1 2026), $4.8 million (Q4 2025), and $7.1 million (Q3 2025), per Business Quant data.